A phase I-II study with carboplatin (C) and weekly paclitaxel (P) in advanced NSCLC

被引：0
|
作者：
Fabi, A
Barduagni, M
De Marco, S
De Marinis, F
Cortesi, E
Foggi, CM
Chiapparino, E
Gareri, R
Venturoli, AL
Cognetti, F
机构：
[1] Regina Elena Canc Inst, Div Med Oncol 1, Rome, Italy
[2] Forlanini Hosp, Div Pneumol, Rome, Italy
[3] Univ Rome La Sapienza, Oncol Serv, Rome, Italy
[4] San Filippo Neri Hosp, Div Oncol, Rome, Italy
[5] Bristol Myers Squibb, Rome, Italy
来源：
EUROPEAN JOURNAL OF CANCER | 1999年 / 35卷
关键词：
D O I：
10.1016/S0959-8049(99)81469-5
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
1049
引用
收藏
页码：S263 / S264
页数：2
相关论文
共 50 条
  • [1] Phase II study of olaratumab with paclitaxel/carboplatin (P/C) or P/C alone in previously untreated advanced NSCLC
    Gerber, David E.
    Swanson, Paul
    Lopez-Chavez, Ariel
    Wong, Lucas
    Dowlati, Afshin
    Pennell, Nathan A.
    Cronier, Damien M.
    Qin, Amy
    Ilaria, Robert, Jr.
    Cosaert, Jan
    Shahir, Ashwin
    Baggstrom, Maria Q.
    LUNG CANCER, 2017, 111 : 108 - 115
  • [2] Weekly paclitaxel in combination with carboplatin: A phase I study in advanced malignancies
    Belani, CP
    Ramanathan, RK
    SEMINARS IN ONCOLOGY, 1999, 26 (06) : 63 - 63
  • [3] Phase I-II study of paclitaxel-carboplatin (PC) weekly combination chemotherapy in esophageal carcinoma.
    D'Addario, G
    Morant, R
    Cerny, T
    ANNALS OF ONCOLOGY, 2000, 11 : 91 - 91
  • [4] Premetrexed combined with paclitaxel in NSCLC phase I-II
    Stathopoulos, George P.
    Dimitroulis, John
    Toubis, Michael
    Katis, Costas
    Karaindros, Dimitris
    Stathopoulos, John
    Koutandos, John
    ANNALS OF ONCOLOGY, 2006, 17 : 223 - 223
  • [5] A Phase I study of a weekly schedule of paclitaxel and carboplatin in patients with advanced carcinoma
    Akerley, W
    Rathore, R
    Ready, N
    Leone, L
    Sikov, W
    Safran, H
    Kennedy, T
    CANCER, 2002, 95 (09) : 2000 - 2005
  • [6] Phase I study of carboplatin, doxorubicin and weekly paclitaxel in patients with advanced ovarian carcinoma
    Hess, V
    Verrill, MW
    Bomphray, CC
    Vaughan, MM
    Allen, M
    Gore, ME
    ANNALS OF ONCOLOGY, 2003, 14 (04) : 638 - 642
  • [7] A phase I study of pazopanib with weekly paclitaxel and carboplatin in advanced solid tumors.
    Chan, Nancy
    Portal, Daniella E.
    Moss, Rebecca Anne
    Silk, Ann W.
    Stein, Mark N.
    Aisner, Joseph
    Malhotra, Jyoti
    Shih, Weichung
    Lin, Hongxia
    Kane, Michael P.
    Mehnert, Janice M.
    Tan, Antoinette R.
    JOURNAL OF CLINICAL ONCOLOGY, 2019, 37 (15)
  • [8] Neoadjuvant Weekly Paclitaxel-Carboplatin Is Effective in Stage I-II Cervical Cancer
    Salihi, Rawand
    Leunen, Karin
    Moerman, Philippe
    Amant, Frederic
    Neven, Patrick
    Vergote, Ignace
    INTERNATIONAL JOURNAL OF GYNECOLOGICAL CANCER, 2017, 27 (06) : 1256 - 1260
  • [9] Phase II study of carboplatin and weekly paclitaxel combination chemotherapy in advanced non-small-cell lung cancer(NSCLC)
    Kisohara, Akira
    Takahashi, Noriaki
    Tsujino, Ichirou
    Sato, Maki
    Horie, Takashi
    ANNALS OF ONCOLOGY, 2004, 15 : 180 - 180
  • [10] Phase I / II Study of Carboplatin, Nab-Paclitaxel, and Concurrent Radiotherapy for Patients with Locally Advanced NSCLC
    Kawano, Y.
    Sasaki, T.
    Yamaguchi, H.
    Hirano, K.
    Nishio, M.
    Satouchi, M.
    Hosokawa, S.
    Morinaga, R.
    Komiya, K.
    Inoue, K.
    Fujita, Y.
    Toyozawa, R.
    Kimura, T.
    Takahashi, K.
    Nishikawa, K.
    Kishimoto, J.
    Nakanishi, Y.
    Okamoto, I.
    JOURNAL OF THORACIC ONCOLOGY, 2018, 13 (10) : S635 - S635
12345